ctrl K

Price Alert

Barinthus Biotherapeutics (BRNS)

NASDAQ: BRNS · Real-Time Price · USD

1.26

-0.02 (-1.25%)

At close: Aug 15, 2025, 3:59 PM

1.33

5.97%

Pre-market: Aug 18, 2025, 07:10 AM EDT

Barinthus Biotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	110.66M	142.09M	194.38M	214.05M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	-8.93M	-4M
Other Long-Term Assets	881K	882K	976K	804K
Receivables	13M	7.94M	12.21M	7.1M
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	2.08M	1.47M	563K	995K
Total Current Assets	125.74M	156.91M	213.04M	226.76M
Property-Plant & Equipment	11.76M	19.4M	15.71M	9.09M
Goodwill & Intangibles	21.95M	37.32M	40.48M	44.06M
Total Long-Term Assets	34.59M	57.6M	57.16M	53.95M
Total Assets	160.33M	214.51M	270.2M	280.71M
Account Payables	2.47M	1.6M	3.75M	2.42M
Deferred Revenue	1.74M	n/a	0.00	182K
Short-Term Debt	1.92M	n/a	n/a	159K
Other Current Liabilities	7.11M	6.01M	1.93M	5.38M
Total Current Liabilities	15.66M	12.6M	12.24M	11.16M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	4.01M	3.15M	2.68M	2.37M
Total Long-Term Liabilities	14.54M	14.91M	14.76M	17M
Total Liabilities	30.19M	27.51M	27M	28.15M
Total Debt	12.01M	12.98M	8.77M	7.22M
Common Stock	1K	1K	1K	1K
Retained Earnings	-237.66M	-176.59M	-103.24M	-108.58M
Comprehensive Income	-25.87M	-23.32M	-33.46M	-8.49M
Shareholders Equity	130.03M	186.78M	242.9M	252.13M
Total Investments	n/a	-11.18M	-8.93M	-4M